Sitagliptin--another option for managing type 2 diabetes in dialysis patients?

Am J Kidney Dis. 2013 Apr;61(4):532-5. doi: 10.1053/j.ajkd.2013.01.004.
No abstract available

Publication types

  • Editorial
  • Research Support, Non-U.S. Gov't
  • Comment

MeSH terms

  • Diabetes Mellitus, Type 2 / drug therapy*
  • Diabetic Nephropathies / drug therapy*
  • Dipeptidyl-Peptidase IV Inhibitors / therapeutic use*
  • Humans
  • Pyrazines / therapeutic use*
  • Sitagliptin Phosphate
  • Triazoles / therapeutic use*

Substances

  • Dipeptidyl-Peptidase IV Inhibitors
  • Pyrazines
  • Triazoles
  • Sitagliptin Phosphate